Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Marques da Silva

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Drug Investigation|July 15, 2010
Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartanPedro Marques da Silva
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 31, 2011
Are all statins the same? Focus on the efficacy and tolerability of pitavastatinPedro Marques da Silva
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|May 1, 2012
[Old and new oral anticoagulants. Pharmacological perspective]Pedro Marques da Silva
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|December 25, 2010
[Intensive cholesterol drug lowering: how to be sure about their safety]Pedro Marques da Silva
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|August 29, 2017
Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failurePedro Marques da Silva, Carlos Aguiar
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 13, 2016
Defining the Place of Ezetimibe/Atorvastatin in the Management of HyperlipidemiaAntónio Miguel Ferreira, Pedro Marques da Silva
Revista Portuguesa De Cardiologia|November 11, 2019
Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID studyPedro Marques da Silva, Carlos Aguiar, João Morais, et al.
European Journal of Case Reports in Internal Medicine|February 14, 2019
Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common TreatmentZsófia Vesza, Catarina Pires, Pedro Marques da Silva
SAGE Open Medical Case Reports|January 11, 2018
<i>Pasteurella</i> infections in a tertiary centre - from cellulitis to multiple-organ failure: Retrospective case seriesZsófia Vesza, Matteo Boattini, Margarida Pinto, et al.
Primary Care Diabetes|December 3, 2014
Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS)Pedro Marques da Silva, Salvador Massano Cardoso, António Miguel Ferreira, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Drug Investigation|July 15, 2010
Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartanPedro Marques da Silva
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 31, 2011
Are all statins the same? Focus on the efficacy and tolerability of pitavastatinPedro Marques da Silva
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|May 1, 2012
[Old and new oral anticoagulants. Pharmacological perspective]Pedro Marques da Silva
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|December 25, 2010
[Intensive cholesterol drug lowering: how to be sure about their safety]Pedro Marques da Silva
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|August 29, 2017
Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failurePedro Marques da Silva, Carlos Aguiar
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 13, 2016
Defining the Place of Ezetimibe/Atorvastatin in the Management of HyperlipidemiaAntónio Miguel Ferreira, Pedro Marques da Silva
Revista Portuguesa De Cardiologia|November 11, 2019
Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID studyPedro Marques da Silva, Carlos Aguiar, João Morais, et al.
European Journal of Case Reports in Internal Medicine|February 14, 2019
Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common TreatmentZsófia Vesza, Catarina Pires, Pedro Marques da Silva
SAGE Open Medical Case Reports|January 11, 2018
<i>Pasteurella</i> infections in a tertiary centre - from cellulitis to multiple-organ failure: Retrospective case seriesZsófia Vesza, Matteo Boattini, Margarida Pinto, et al.
Primary Care Diabetes|December 3, 2014
Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS)Pedro Marques da Silva, Salvador Massano Cardoso, António Miguel Ferreira, et al.
Pageof 3